Lyciumin A, a cyclic octapeptide, exhibits inhibitory activity on proteases, renin and angiotensin-converting enzyme . Lyciumin A can be used for the research of hypertension In Vitro Lyciumin A inhibits renin activities by 19.4% (40 μg/mL). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:proteases, renin, angiotensin-converting enzyme
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Lyciumin A
CAS number:125708-06-7 molecular formula:C42H51N9O12
overview
compound introduction
Specs
| Chinese alias | 枸杞素A | ||
| English alias | 11-(hydroxymethyl)-2-[[3-(4-hydroxyphenyl)-2-[[1-(5-oxopyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl]amino]propanoyl]amino]-3,6,9,12-tetraoxo-5-propan-2-yl-1,4,7,10,13-pentazatricyclo[14.6.1.017,22]tricosa-16(23),17,19,21-tetraene-14-carboxylic acid | Lyc | ||
| CAS number | 125708-06-7 | molecular formula | C42H51N9O12 |
| molecular weight | 873.91 g/mol | Exact mass | ≥99% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





